10612381

Source:http://linkedlifedata.com/resource/pubmed/id/10612381

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018823, umls-concept:C0021079, umls-concept:C0021080, umls-concept:C0205263, umls-concept:C0348016, umls-concept:C0596545
pubmed:issue	12
pubmed:dateCreated	2000-1-27
pubmed:abstractText	Intravenous thymoglobuline (125 mg a day for 3 days, Institut Mérieux, France) has been used to induce immunosuppression following heart transplantation. Cyclosporine and prednisone, with and without azathioprine or mycophenolate mofetil were used as maintenance immunosuppression.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9102703
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antilymphocyte Serum, http://linkedlifedata.com/resource/pubmed/chemical/Azathioprine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1053-2498
pubmed:author	pubmed-author:CarrierMM, pubmed-author:PellerinMM, pubmed-author:PelletierG BGB, pubmed-author:PelletierL CLC, pubmed-author:PerraultL PLP, pubmed-author:RobitailleDD, pubmed-author:WhiteMM
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1218-23
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10612381-Adult, pubmed-meshheading:10612381-Analysis of Variance, pubmed-meshheading:10612381-Antilymphocyte Serum, pubmed-meshheading:10612381-Azathioprine, pubmed-meshheading:10612381-Coronary Artery Disease, pubmed-meshheading:10612381-Cyclosporine, pubmed-meshheading:10612381-Female, pubmed-meshheading:10612381-Heart Transplantation, pubmed-meshheading:10612381-Humans, pubmed-meshheading:10612381-Immunosuppression, pubmed-meshheading:10612381-Immunosuppressive Agents, pubmed-meshheading:10612381-Injections, Intravenous, pubmed-meshheading:10612381-Lymphocyte Subsets, pubmed-meshheading:10612381-Male, pubmed-meshheading:10612381-Mycophenolic Acid, pubmed-meshheading:10612381-Prednisone, pubmed-meshheading:10612381-Retrospective Studies, pubmed-meshheading:10612381-T-Lymphocytes
pubmed:year	1999
pubmed:articleTitle	A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
pubmed:affiliation	Department of Surgery, Montreal Heart Institute and University of Montreal, Quebec, Canada. carrier@icm.umontreal.ca
pubmed:publicationType	Journal Article, Clinical Trial